| scholarly article | Q13442814 |
| P50 | author | Michael J Kozal | Q61990588 |
| Amy C Justice | Q42395670 | ||
| Matthew B. Goetz | Q44007949 | ||
| P2093 | author name string | R Scott Braithwaite | |
| Mark S Roberts | |||
| Cynthia Gibert | |||
| Maria Rodriguez-Barradas | |||
| Shawn L Fultz | |||
| Larry Mole | |||
| Chung Chou H Chang | |||
| P2860 | cites work | A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care | Q45333065 |
| Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. | Q50996165 | ||
| Development and verification of a "virtual" cohort using the National VA Health Information System. | Q51937405 | ||
| A general method of compliance assessment using centralized pharmacy records. Description and validation | Q68455320 | ||
| Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication | Q80117376 | ||
| A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV | Q80967260 | ||
| Problem drinking and medication adherence among persons with HIV infection | Q28360406 | ||
| Profile of Medicare beneficiaries with AIDS: application of an AIDS casefinding algorithm. | Q33645777 | ||
| Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy | Q34381830 | ||
| Paradoxes of adherence and drug resistance to HIV antiretroviral therapy | Q35715028 | ||
| Explaining variability in the relationship between antiretroviral adherence and HIV mutation accumulation | Q36615564 | ||
| Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection | Q36618299 | ||
| Estimating causal effects from large data sets using propensity scores | Q36893066 | ||
| Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic | Q39600105 | ||
| Adherence to protease inhibitor therapy and outcomes in patients with HIV infection | Q39605935 | ||
| High levels of adherence do not prevent accumulation of HIV drug resistance mutations | Q39659192 | ||
| Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection | Q39670784 | ||
| The assessment of refill compliance using pharmacy records: methods, validity, and applications | Q41361915 | ||
| Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection. | Q44043469 | ||
| Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team | Q44088437 | ||
| Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection | Q44445534 | ||
| The NEAT study: a 48-week open-label study to compare the antiviral efficacy and safety of GW433908 versus nelfinavir in antiretroviral therapy-naive HIV-1-infected patients | Q44715515 | ||
| Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems | Q44853629 | ||
| SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients | Q44967510 | ||
| Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen | Q45272010 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virology | Q7215 |
| HIV | Q15787 | ||
| veteran | Q193891 | ||
| anti-retroviral agent | Q50430310 | ||
| P304 | page(s) | 1579-1589 | |
| P577 | publication date | 2007-07-01 | |
| P1433 | published in | AIDS | Q4651863 |
| P1476 | title | Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies | |
| P478 | volume | 21 |
| Q35872422 | A retrospective study of HIV antiretroviral treatment persistence in a commercially insured population in the United States |
| Q42552927 | A study of financial incentives to reduce plasma HIV RNA among patients in care. |
| Q35788408 | Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy |
| Q44921660 | Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting |
| Q52685421 | Adherence and virologic outcomes among treatment-naïve veteran patients with human immunodeficiency virus type 1 infection. |
| Q36445942 | Adherence to hepatitis C virus therapy in HIV/hepatitis C-coinfected patients |
| Q35034399 | Adjusting alcohol quantity for mean consumption and intoxication threshold improves prediction of nonadherence in HIV patients and HIV-negative controls |
| Q35040590 | Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection |
| Q35185677 | Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives? |
| Q40069947 | Antiretroviral adherence among rural compared to urban veterans with HIV infection in the United States. |
| Q40129344 | Cardiovascular outcomes among HIV-infected veterans receiving atazanavir |
| Q42209986 | Clinical course and quality of care in ART-naïve patients newly presenting in a HIV outpatient clinic. |
| Q34271951 | Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study |
| Q35202689 | Comparative value of four measures of retention in expert care in predicting clinical outcomes and health care utilization in HIV patients |
| Q48631709 | Comparing adherence to two different HIV antiretroviral regimens: an instrumental variable analysis |
| Q35007948 | Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study |
| Q37184269 | Correlates of Combination Antiretroviral Adherence Among Recently Diagnosed Older HIV-Infected Adults Between 50 and 64 years |
| Q34768650 | Cost-effectiveness of antiretroviral regimens in the World Health Organization's treatment guidelines: a South African analysis |
| Q34546597 | Do benefits of earlier antiretroviral treatment initiation outweigh harms for individuals at risk for poor adherence? |
| Q37475726 | Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice? |
| Q37656281 | Economic evaluation of mobile phone text message interventions to improve adherence to HIV therapy in Kenya |
| Q24235724 | Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals |
| Q37137838 | Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults |
| Q35549547 | Effects of combined alcohol and anti-HIV drugs on cellular stress responses in primary hepatocytes and hepatic stellate and kupffer cells |
| Q34546423 | Evaluating interventions to improve antiretroviral adherence: how much of an effect is required for favorable value? |
| Q36016811 | Evaluating the impact of prioritization of antiretroviral pre-exposure prophylaxis in New York |
| Q35168930 | Food insecurity is associated with poor virologic response among HIV-infected patients receiving antiretroviral medications |
| Q40864377 | HIV Treatment in Resource-Limited Environments: Treatment Coverage and Insights |
| Q33873878 | How do different eligibility guidelines for antiretroviral therapy affect the cost-effectiveness of routine viral load testing in sub-Saharan Africa? |
| Q39961994 | Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy |
| Q37463958 | Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007. |
| Q36303074 | Improvement in the health of HIV-infected persons in care: reducing disparities |
| Q35418299 | Incarceration and health outcomes in HIV-infected patients: the impact of substance use, primary care engagement, and antiretroviral adherence |
| Q36631498 | Intentional non-adherence to medications among HIV positive alcohol drinkers: prospective study of interactive toxicity beliefs |
| Q24597052 | Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies |
| Q58864351 | Measuring Adherence to Antiretroviral Treatment: The Role of Pharmacy Records of Drug Withdrawals |
| Q59360885 | Medication Side Effects and Retention in HIV Treatment: A Regression Discontinuity Study of Tenofovir Implementation in South Africa and Zambia |
| Q44147560 | Medication persistence of HIV-infected drug users on directly administered antiretroviral therapy |
| Q39257931 | Minority Men Who Have Sex with Men Demonstrate Increased Risk for HIV Transmission |
| Q37788590 | Mother-to-Child Transmission (MTCT) of HIV and Drugs of Abuse in Post-Highly Active Antiretroviral Therapy (HAART) Era |
| Q39060951 | Odds of Viral Suppression by Single-Tablet Regimens, Multiple-Tablet Regimens, and Adherence Level in HIV/AIDS Patients Receiving Antiretroviral Therapy |
| Q33634206 | One year survival of HIV-infected veterans with CD4 < 100 cells/mm3: data from a veteran cohort |
| Q27021762 | Outcomes for efavirenz versus nevirapine-containing regimens for treatment of HIV-1 infection: a systematic review and meta-analysis |
| Q36142875 | Patient-reported symptoms on the antiretroviral regimen efavirenz/emtricitabine/tenofovir |
| Q34555082 | Personal health record use and its association with antiretroviral adherence: survey and medical record data from 1871 US veterans infected with HIV. |
| Q34699180 | Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring |
| Q35737660 | Poorer ART outcomes with increasing age at a large public sector HIV clinic in Johannesburg, South Africa. |
| Q35952818 | Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients |
| Q54983515 | Predicting poor adherence to antiretroviral therapy among treatment-naïve veterans infected with human immunodeficiency virus. |
| Q34474961 | Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study |
| Q37084526 | Predictors of suboptimal virologic response to highly active antiretroviral therapy among human immunodeficiency virus-infected adolescents: analyses of the reaching for excellence in adolescent care and health (REACH) project |
| Q35717749 | Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine or efavirenz in Uganda: a prospective non-randomized study |
| Q36006322 | Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study |
| Q53086924 | State of the ART: clinical efficacy and improved quality of life in the public antiretroviral therapy program, Free State province, South Africa. |
| Q35608074 | Switching antiretroviral therapy to minimize metabolic complications |
| Q52729705 | Tenofovir-Associated Bone Adverse Outcomes among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant Antiretrovirals. |
| Q91862863 | The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia in a National Cohort of Veteran Patients with HIV |
| Q43580735 | The effect of increased travel reimbursement rates on health care utilization in the VA. |
| Q36125599 | The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis |
| Q40783234 | Time to Viremia for Patients Taking their First Antiretroviral Regimen and the Subsequent Resistance Profiles |
| Q31150646 | Use of pharmacy refill data as a measure of antiretroviral adherence |
| Q41676319 | Using mechanistic models to simulate comparative effectiveness trials of therapy and to estimate long-term outcomes in HIV care |
| Q40181531 | Utilization of travel reimbursement in the Veterans Health Administration |
| Q34817650 | Viral suppression and antiretroviral medication adherence among alcohol using HIV-positive adults |
| Q46269343 | Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected persons. |
Search more.